Citigroup’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,966
Closed -$1.2K 6117
2024
Q4
$1.2K Hold
9,966
﹤0.01% 5585
2024
Q3
$1.37K Hold
9,966
﹤0.01% 5434
2024
Q2
$1.46K Hold
9,966
﹤0.01% 5357
2024
Q1
$1.45K Hold
9,966
﹤0.01% 5410
2023
Q4
$2K Hold
9,966
﹤0.01% 5419
2023
Q3
$1.67K Hold
9,966
﹤0.01% 5010
2023
Q2
$1.99K Hold
9,966
﹤0.01% 5288
2023
Q1
$2.11K Hold
9,966
﹤0.01% 5086
2022
Q4
$1.62K Hold
9,966
﹤0.01% 5300
2022
Q3
$2K Sell
9,966
-26,785
-73% -$7.09K ﹤0.01% 5592
2022
Q2
$8K Sell
36,751
-37,395
-50% -$9.52K ﹤0.01% 5478
2022
Q1
$25K Buy
74,146
+47,018
+173% +$15.4K ﹤0.01% 5048
2021
Q4
$8K Buy
27,128
+125
+0.5% +$56 ﹤0.01% 5615
2021
Q3
$14K Sell
27,003
-379,595
-93% -$224K ﹤0.01% 5394
2021
Q2
$339K Buy
406,598
+300,195
+282% +$280K ﹤0.01% 3942
2021
Q1
$168K Buy
+106,403
New +$174K ﹤0.01% 4100
2020
Q1
Sell
-4,650
Closed -$2K 7886
2019
Q4
$2K Hold
4,650
﹤0.01% 7580
2019
Q3
$2K Sell
4,650
-1,670
-26% -$518 ﹤0.01% 7579
2019
Q2
$1K Sell
6,320
-5,860
-48% -$1.78K ﹤0.01% 7708
2019
Q1
$4K Buy
12,180
+9,749
+401% +$8.6K ﹤0.01% 7466
2018
Q4
$5K Sell
2,431
-8,897
-79% -$14.1K ﹤0.01% 7373
2018
Q3
$22K Buy
11,328
+5,660
+100% +$12.1K ﹤0.01% 7049
2018
Q2
$11K Buy
+5,668
New +$11.4K ﹤0.01% 7166

Other funds holding ZOM

Citigroup's ZOM Position: Q1 2025 in Review

Citigroup sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 9,966 shares — an estimated $1.2K sold.

Citigroup first reported a position in ZOM in Q2 2018 and held it in 23 quarters. The position peaked at $339K in Q2 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Citigroup reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 9,966 Zomedica Corp. shares in Q1 2025, an estimated $1.2K.
  • Citigroup first reported a position in Zomedica Corp. in Q2 2018 and held it in 23 quarters.
  • Citigroup's Zomedica Corp. position peaked at $339K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.